Biotechnology market research reports by DelveInsight

• MOG Antibody Disease - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" MOG Antibody Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted MOG Antibody Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... Read More

• Anti-CD40 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD40 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD40 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Anti-CD152 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD152 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More

• Anti-CD37 Antibody - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  “ Anti-CD37 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  “ Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022 ” report provides comprehensive insights about 7+ companies and 8+ pipeline drugs in Protein tyrosine phosphatase non receptor type 11 antagonists pipeline landscape. It covers the pipeline drug profiles, includ ... Read More

• Dense Deposit Disease - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Dense Deposit Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Dense Deposit Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More

< prev 4 5 6 7 8 9 next >